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Notch signalling acts in virtually every tissue during the lifetime of metazoans. Recent studies have pointed to
multiple roles for Notch in stem cells during quiescence, proliferation, temporal specification, and maintenance of
the niche architecture. Skeletal muscle has served as an excellent paradigm to examine these diverse roles as
embryonic, foetal, and adult skeletal muscle stem cells have different molecular signatures and functional
properties, reflecting their developmental specification during ontology. Notably, Notch signalling has emerged as a
major regulator of all muscle stem cells. This review will provide an overview of Notch signalling during myogenic
development and postnatally, and underscore the seemingly opposing contextual activities of Notch that have lead
to a reassessment of its role in myogenesis.
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Notch signalling is one the major regulatory pathways
that define multicellular development, principally by dic-
tating the fate of one cell in relation to that of its neigh-
bouring cell [1]. This pathway relies on cell-to-cell
communication, by virtue of the fact that both the Notch
receptors (Notch1-4 in mammals) and their ligands
(Delta-like1, Delta-like4, Jagged1, and Jagged2 in mam-
mals) are transmembrane proteins (note: Dll3 is not con-
sidered, as it does not act as a Notch ligand, [2,3]). The
cleaved, intracellular domain of Notch, NICD, is also a
transcriptional coactivator [4-6] that interacts with RBPJ
[7-10] and induces its binding to DNA to regulate gene
expression [11,12].
Although the fundamental role of Notch signalling
during development has been well studied, its function
in the adult organism was overshadowed until the stem
cells of fully-grown and aged organisms became a sub-
ject of systematic research. Today, we know that Notch
activity is critical for the maintenance of diverse types of
adult somatic stem cells, both quiescent and proliferat-
ing [13-17]. In the skeletal muscle, adult stem (satellite)
cells that are quiescent during homeostasis, have robust* Correspondence: shahragim.tajbakhsh@pasteur.fr
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ling activities.
The origin of satellite cells in the body can be traced
back to mesodermal cells of the dermomyotome [18], a
transient epithelial structure of the somites formed in
the mouse around embryonic day (E)9. These skeletal
muscle founder stem cells proliferate and express the
paired-box/homeodomain transcription factors Pax3 and
Pax7 [19-21]. They undergo myogenic specification fol-
lowing the sequential expression of the bHLH Myogenic
Regulatory Factors (MRFs), Myf5, Mrf4, Myod, and sub-
sequently the differentiation gene Myogenin [22-24].
Juvenile satellite cells that are Pax7+ are observed under
the myofibre basement membrane from E16.5 [20] and
they act as reservoirs of adult satellite cells that emerge
between 2–3 weeks postnatally [22,25,26].
The main focus of this review is to examine the role of
the Notch pathway during the establishment, mainten-
ance, and activation of satellite cells in the mouse. We
speculate on the cellular contexts, during mouse devel-
opment and postnatally, that ensure proper activation of
Notch signalling in skeletal muscle stem cells. Moreover,
we underscore the opposing contextual outcomes of
Notch activity and propose alternative views for its role
during quiescence and regeneration.ed Central Ltd. This is an Open Access article distributed under the terms of the
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stem cells during development
Notch signalling plays a central role in maintaining
muscle stem cells during prenatal and postnatal skeletal
muscle development. Therefore, there is a requirement
for continuous Notch signalling during the ontogeny of
muscle, as well as during adult muscle homeostasis. So,
what is the identity and the source of the ligand required
to maintain appropriate Notch signalling in the right
cells at the right time?
In the embryo, the major player appears to be Delta-
like1 (Dll1), provided mainly by the committed myoblasts
[13,27-29]. These cells are Myod+ that, in analogy to neur-
onal bHLH factors [30], induces the expression of Dll1
[31] to signal to upstream cells and sustain the stem/
progenitor cell population by direct cell-cell interaction.
This feedback mechanism of receptor/ligand regulation,
utilized in many other cell systems [32,33], is coherent with
the transcriptional signature of upstream (high levels of
Pax7, “Pax7Hi”) and differentiating (Pax7Low) myogenic
cells that show high levels of Notch receptors (Notch-1,
-2,-3) and activity in the former, and high Dll1 ligand
expression in the latter [13]. Notably, the Pax7 population
in the mouse does not express detectable levels of Dll4,
and the transcripts of the Notch ligand and target Jagged-1
are detectable only in the Pax7Hi cells that receive Notch
signalling (PM, ST, unpublished observations).
The prevalence of Dll1 in committed myogenic cells is
consistent with the muscle phenotypes in mouse em-
bryos with reduced levels of this ligand (hypomorphic
over null Dll1 allele), where there is severe muscle hypo-
trophy due to precocious differentiation of the muscle
stem cell population [29]. With the caveat that this was
a germline mutation and not cell type specific, this study
strongly suggests that Dll1 is a necessary and sufficient
Notch ligand for the maintenance of myogenic stem
cells during embryogenesis. Similarly, loss of myogenic
stem cells was accompanied by increased differentiation
in mouse embryos upon muscle-specific, conditional de-
letion of Rbpj [34]. In a complementary approach, it was
shown that Myf5Cre driven expression of constitutively
active Notch1 (Myf5Cre:R26stop-NICD) maintained up-
stream myogenic cells undifferentiated and Pax7+, even
in the absence of differentiating progeny [35]. By ex-
trapolation, we can conclude that Dll1-triggered canon-
ical Notch signalling fulfils the requirements as the
principal pathway, sufficient to autonomously maintain
embryonic myogenic cells throughout development.
A distinct source of Dll1 ligand was described for a
subpopulation of muscle progenitors during early myo-
genesis in the chick embryo [36]. In that study, migrat-
ing neural crest cells expressing Dll1 trigger the
transient activation of Notch signalling in muscle pro-
genitors specifically within the dorsal dermomyotome ofthe somite, as these delaminate to commit to myogen-
esis. This attractive regulatory mechanism, which in-
volves the coordination of different cell types, remains
to be tested in diverse model organisms and in other
muscle progenitors outside the dorsomedial lip of the
dermomyotome.
Notch receptors and their ligands in satellite cells
In adult homeostatic muscle, quiescent satellite cells ex-
press Notch −1, -2, and −3 as well as high levels of the
Notch/Rbpj targets Hey1, HeyL, and Hes1, thereby
reflecting high Notch activity. Abrogation of Notch
signalling by targeted deletion of Rbpj results in the
spontaneous differentiation of this cell population.
Therefore, satellite cells are sustained in a quiescent
state by canonical Notch activity [13,37]. Interestingly,
Notch3 germline knock-out mice have a seemingly
opposite phenotype, with an abnormally high number of
satellite cells and hypertrophic regenerated muscle even
after seven rounds of injury, indicating an antagonistic
function with the other Notch receptors [38]. Although
canonical Notch signalling is transduced by Rbpj, how
this transcription factor relays signalling from each of
the Notch receptors is a critical question that could
unveil further surprises. Conditional deletion of Notch3,
as well as that of Notch-1 and −2, would provide useful
information for the functional relationship of the Notch
paralogues in satellite cell homeostasis.
Based on the anatomical position of adult satellite cells
between the myofibre and the basement membrane, the
muscle fibre is the most likely source of ligand. However,
the lack of reliable mouse Dll1 antibodies has hindered
the direct visualization of the protein, especially relative
to the position of the satellite cells. Genetic, inducible
depletion of Dll1 and/or Dll4 specifically in the myofi-
bres should be performed to validate the main source of
the ligand. The basal lamina of the basement membrane,
a cell-free extracellular matrix protein rich structure, is
located in apposition to the myofibre. Although proteo-
glycans of the basal lamina bind secreted cytokines and
other signalling molecules [39], they are not expected to
bind Notch ligands as these are transmembrane proteins
and their soluble form is not active [40,41].
Alternatively, several cell types that reside outside the
basement membrane, including pericytes, endothelial cells,
PICs (Pw1+ interstitial cells), fibro-adipogenic and mesen-
chymal cells, could potentially act as source of ligand [42].
In addition, satellite cells have been shown to be closely
associated to capillaries of human and mouse muscle [43].
Though no apparent physical contact has been demon-
strated yet between satellite and endothelial or pericyte
cells, the latter cell types might contribute to Notch acti-
vation in the satellite cells. Indeed, both in vertebrates and
invertebrates Dll-bearing cellular protrusions (filopodia)
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been described [44-46], providing a possible mode of cell
interactions crossing the basement membrane. Moreover,
even in the absence of cell contact, soluble factors secreted
by interstitial cells might enhance stimulation of the
Notch pathway in satellite cells by a paracrine mechanism.
The muscle fibre, its ensheathing basement mem-
brane, as well as the various cell types indicated above
provide a complex microenvironment that maintains sat-
ellite cells in a G0 reversible cell cycle state, whilst
retaining their extraordinary regenerative potential.
Disruption of this satellite cell niche invariably leads to
exit from quiescence and entry into a phase of active
proliferation. The status of Notch signalling in satellite
cells during the transition from G0-exit to the prolifera-
tion of myogenic progeny cells has been difficult to
decipher. Recent studies point to a more complex role
than previously anticipated.
Proliferating and Quiescent myogenic stem cells:
two distinct cell states regulated by Notch
In the mouse embryo, Notch signalling is essential for
the maintenance of proliferating Pax7+ cells, although it
appears not to be required for their emergence in the
dermomyotome [29,34]. In the adult, active Notch sig-
nalling is critical for sustaining quiescent satellite cells
during homeostasis [13,37]. In addition to maintaining
quiescence, Notch activity is likely to facilitate the transi-
tion into that cell state, as forced expression of NICD
promotes precocious cell cycle exit prenatally, charac-
terised by the quiescence marker signature: Pax7+, CalR+
(CalR: Calcitonin receptor, marker of adult satellite
cells), Myod— [35]. To date, it is unclear how Notch
maintains stem cells in a proliferative state during devel-
opment and in a quiescent state in the adult. One com-
mon feature is by preventing differentiation thereby
raising the question whether the quiescent state reflects
an absence of proliferation and differentiation or a bona
fide defined cell state.
Notch signalling collapses during satellite cell
activation: a prerequisite or consequence?
In the context of skeletal muscle repair, previous reports
suggested that satellite cell activation and subsequent pro-
liferation is driven by Notch signalling [47-49]. This no-
tion was in agreement with the role of this signalling
pathway during development. More recent studies, how-
ever, have fundamentally changed this view by examining
the activity of the Notch pathway directly in myogenic
cells in vivo. Here we highlight the recent reports that
point to a more nuanced role for Notch during adult myo-
genesis. We will first describe the key steps that character-
ise satellite cell activation, then discuss the role of Notch
signalling during these critical stages.One feature of G0-exit is the prolonged G1 phase that
follows the breaking of quiescence. This is indeed the
case for satellite cells: in injured muscles, the first
S-phase of activated satellite cells in vivo initiates
between 14 h and 18 h post-injury (Notexin-injury),
[50]. Accordingly, the first mitoses of quiescent satellite
cells isolated by FACS are observed between 18-27 h after
plating in low oxygen [13,50]. To date, the earliest mo-
lecular marker of activated satellite cells is phosphorylated
p38 (pp38α/β), followed by Myod [51,52,53]. Also, Myf5 is
highly upregulated upon activation [54,55], but unlike
Myod, Myf5 protein is detectable in the majority of quies-
cent satellite cells [55]. Interestingly, during the G1-phase
following quiescence, Myod does not promote differenti-
ation, but instead it directly regulates the expression of
Cdc6, a gene involved in rendering chromatin accessible
for DNA replication [53,56]. Once activated, myoblasts
enter the cell cycle and continue to divide every 7-8 h
(both in vivo and in culture in low O2; [50]) until the ma-
jority progress to terminal differentiation by downregulat-
ing Pax7 and upregulating Myogenin. A fraction of the
proliferating population, however, is able to self-renew
and return to quiescence (Pax7+/Myod-).
It was previously proposed that Notch signalling is the
driving force for the proliferation of activated satellite
cells, and this notion was consistent with the general pro-
mitotic action of NICD in other systems [57,58]. However,
recent experimental evidence has revised our view of the
role of Notch signalling during activation. These are based
on: 1) the drastic decrease of endogenous Notch activity
in vivo following muscle injury; 2) the continued prolifera-
tion and efficient regeneration of Rbpj null satellite cells;
3) the hindered proliferation of activated satellite cells that
express constitutively active NICD.
Notably, analysis of activated myoblasts isolated from
regenerating muscles showed that endogenous Notch
signalling is dramatically reduced upon activation, rela-
tive to the non-activated satellite cells [13,37]. In both
studies, activated satellite cells from hindlimb muscles
injured either by Notexin venom [13] or BaCl2 salt [37]
were analysed by quantitative RT-PCR. Regardless of the
injury model, the expression of the established Notch/
Rbpj targets Hey1, Hey2, HeyL Hes5, and Hes1 was re-
duced by up to 80-90% compared to quiescent satellite
cells. Of note, only one Hes family member, Hes6, was
found to be upregulated. However, Hes6 is not a direct
Notch/Rbpj target, and it promotes myogenic differenti-
ation [59]. Importantly, microarray data comparing qui-
escent with activated satellite cells (isolated by FACS)
in vivo, confirmed that Notch signalling was dramatically
reduced in proliferating myoblasts [60]. Consistently,
analysis of GFP+ cells from injured transgenicTg:Pax7-
nGFP mice showed that the reduction in Notch activity
takes place almost immediately (within 20 hours) after
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in vivo [50]. Subsequently, Notch signals weakly in the
proliferating myoblasts and it starts to increase again by
day 4–5 post-injury, a time point that correlates with the
appearance of differentiated, Myogenin+ cells in the
population and a decline in overall proliferation of the
myogenic cells. We propose that the upregulation of
Notch during regeneration, reflects the Pax7Hi, self-
renewing myogenic cells. Maximal levels of Notch activ-
ity are then restored by days 20–30 post-injury, corre-
sponding to tissue homeostasis and re-establishment of
self-renewed satellite cells. Therefore, the majority of
myogenic cells exhibit little to no Notch activity imme-
diately following satellite cell activation at a time when
these cells exit quiescence to undergo exponential ex-
pansion (Figure 1).
It is clear also that during regeneration, activated myo-
blasts interact with other cell types, including infiltrating
inflammatory cells [61,62] and fibro/adipogenic progeni-
tors [63]. These interactions might be productive in na-
ture, at least in part, via Notch signalling. On this point,
manipulations of the Notch pathway by injection of in-
hibitory or activating reagents in regenerating muscle
can potentially affect myogenic and non-myogenic cell
populations thereby resulting in indirect unrelated phe-
notypes. Moreover, discrepancies between compounds,
or mutations targeting the Notch or Rbpj genes, could
expose putative non-canonical functions, both of the re-
ceptors and Rbpj.
In accordance with the expression data indicated above,
genetic analysis of mice with activated or blocked Notch
signalling support the view that elevated Notch signalling
is not a requirement and likely it is incompatible with
transit amplification of myoblasts. The dispensability of
Notch activity during myoblast proliferation is illustrated
by the phenotypes of Rbpj null mice in the context of re-
generation. When muscles with Rbpj null satellite cells
were injured (injury performed 16 days after tamoxifen-
induced Rbpj gene deletion to ensure complete clearance
of protein), tissue repair was overtly normal with only
slightly smaller muscle fibres ([13], and data not shown;
Figure 2). Moreover, the first mitosis of cultured Rbpj null
satellite cells was similar in timing to control Rbpj+/−
cells, as scored by videomicroscopy [13]. Furthermore,
Rbpj null cells can amplify in culture for the first 3–4 days,
that is, before significant differentiation takes place. In a
complementary study, it was shown that quiescent
satellite cells expressing constitutively activated Notch1
(Pax7CreERT2: R26stop-NICD), failed to exit from quiescence,
as subsequent proliferation was significantly hindered
[64]. Taken together, these data strongly suggest that a
temporary decrease in Notch/Rbpj signalling at the time
of satellite cell activation is a prerequisite for transit amp-
lification of the myogenic population.A seemingly contradictory observation is that freshly
isolated canine satellite cells plated on Dll1 ligand, ex-
panded more than non-treated cells [65]. One major dif-
ference between this and the Pax7CreERT2: R26stop-NICD
experiment cited above, is that cells were exposed to the
ligand after their isolation, hence they were already acti-
vated. If Notch downregulation is indeed critical for the
Myod-driven G1/S transition, it is possible that some of
the dissociated cells were already engaged in the Myod
program. Alternatively, chronic Notch signalling in cul-
ture might result in the eventual amplification of the cell
population after an initial delay. These seemingly dispar-
ate observations might expose qualitative differences be-
tween the first G1/S transition, and those taking place
during myogenic cell amplification.
A model for Notch signalling during early satellite
cell activation and homeostasis
In an attempt to rationalize the contextual roles of
Notch signalling, we propose that the immediate col-
lapse in activity following injury reflects the physical dis-
sociation of satellite cells from the ligand source (likely
the myofibre). The observation that pp38α/β and Myod
are early markers of activated satellite cells is also coher-
ent with a downregulation of Notch signalling, as both
have been shown to be inhibited by activated Notch
[35,51]. Indeed, it is reasonable to expect that Notch sig-
nalling should be transiently shut-off in order to allow
the expression of Myod, whose activity via Cdc6 is im-
portant for exiting quiescence [53] (Figure 1). The in-
crease in Notch activity at day 4–5 post-injury could be
the outcome of signal emitting (Dll1+/Myog+) and signal
receiving (Pax7Hi) cells, either implicating asymmetric or
symmetric cell divisions. Analysis at the single-cell level
would be required to investigate if the residual Notch
activity scored in proliferating myogenic cells is re-
stricted to a specific subpopulation, for example the self-
renewing Pax7Hi cells.
Notably, during homeostasis, loss of Rbpj activity re-
sults in depletion of the satellite cell pool after a delayed
period of 5–7 weeks [13,37]. In stark contrast to acti-
vated satellite cells, the majority of the Rbpj null cells
differentiate directly in the absence of muscle injury,
without entering S-phase, then they fuse with the myofi-
bres (Figure 2). This observation strongly suggests that
in the context of normal satellite cell turnover, Notch ac-
tivity is required for executing the G1/S transition. Ana-
lysis of Notch null clones in the Drosophila eye imaginal
disc clearly demonstrates that Notch is required to
overcome the G1-S check-point [66], consistent with the
observations cited above. The finding that during regen-
eration Rbpj null satellite cells undergo, seemingly nor-
mally, the first G1/S phase following quiescence and





































Figure 1 Notch signalling activity during muscle regeneration. Upper panel: In wild type muscle, quiescent, G0-arrested satellite cells have
high Notch activity (purple line), which maintains Pax7 and inhibits Myod (indirectly: dotted line) and Myogenin (directly via Hey1) expression.
Immediately after activation, satellite cells downregulate Notch activity and express Myod that is required for appropriate Cdc6 expression and S-phase
entry. During the amplification phase high Notch activity is restricted to upstream, Pax7Hi cells that remain undifferentiated and self-renew to replenish
the satellite cell pool. Notch activation is triggered by Dll1-bearing differentiating myoblasts. Non-muscle cells, like infiltrating inflammatory cells and
fibro/adipogenic progenitors could also trigger or influence Notch activation. The expression of Dll ligands by the mature myofibres is likely, but remains
to be demonstrated. Lower panel: Rbpj null satellite cells (no Notch activity: dotted purple line) enter the cell cycle normally and start proliferating. Mutant
satellite cells differentiate faster (yellow cells) and fail to self-renew.
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during homeostasis. Once again, these contrasting be-
haviours underscore the distinct contextual outcomes of
Notch activity in homeostasis vs. injury. Interestingly, ina model where constitutive expression of NICD was
maintained in the upstream myogenic population
(Myf5Cre-NICD), proliferating myogenic cells proceeded














BrdU labeled chromosomes Non labeled chromosomes
Notch activity Self-renewalNo Notch activity
BrdU BrdU
S-phase boycott
Figure 2 Differential outcomes of loss of Notch activity during regeneration and tissue turnover. During regeneration (left) both wild type
and Rbpj null myoblasts proliferate and form new muscle fibres. In the absence of Notch signalling, the size of the amplified population is smaller since
the cells fail to self-renew. During tissue homeostasis (right) a small fraction of satellites cells exit quiescence and divide (red chromosomes, BrdU+) to give
rise to new satellite cells and fusion-competent myoblasts. Satellite cell specific deletion of Rbpj results in an increase in the number of cells that exit
quiescence; these cells differentiate spontaneously. In sharp contrast to wild type cells the majority of Rbpj null satellite cells become Myogenin-positive
without going through S-phase (black chromosomes).
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cycle to adopt a quiescent state late during foetal devel-
opment. Here too, there are seemingly opposing behav-
iours for NICD: compatible with proliferating myogenic
cells during early embryogenesis, and with the quiescent
state in the late foetal phase [35]. These findings lead us
to propose that Notch plays a role as facilitator, rather
than an instigator, of cell fate decisions in this scenario,
leaving the door open to explore alternative pathways
that could promote stem cell quiescence.
Towards understanding what lies downstream of
Notch signalling
An important initial step towards understanding the devel-
opmental outputs of Notch signalling activation is to iden-
tify its downstream targets and the degree of conservation
under diverse cellular contexts. In an attempt to address
this question, a whole-genome ChIP-seq screen was per-
formed for direct Rbpj/NICD targets in cultured myogenic
cells, under activated or inhibited Notch signalling [11].
From this study, two points are pertinent to consider.
First, in mouse muscle cells, binding of Rbpj to DNA is
regulated dynamically by Notch signalling, thereby ex-
tending across-species, and at genome-wide scale, thebinding behaviour of Drosophila Rbpj to the E(spl) gene
cluster [12]. In other words, Rbpj is poorly bound, or not
at all, to DNA in the absence of Notch signalling. By con-
trast, activation of Notch signalling results in recruitment
of Rbpj together with NICD to enhancers/promoters, and
subsequent activation of transcription. The dynamic asso-
ciation of Rbpj to DNA contradicted the prevalent view
that this transcription factor statically occupies its binding
sites, while exchanging repressors for activators in re-
sponse to NICD. Unexpectedly, a second category of
binding-sites was identified and these sequences were not
co-occupied by NICD, but Rbpj was bound constitutively.
Interestingly, this screen uncovered a number of Rbpj/
NICD enhancers linked to genes encoding extracellular
matrix associated proteins. This raises the intriguing
possibility that skeletal muscle stem cells can partially
contribute to the composition of their niche via
cell-autonomous, Notch-regulated mechanisms. Such a
mechanism is in agreement with a recent report that
Notch signals control the homing of satellite cells by in-
fluencing the proper assembly of components in the basal
lamina [67]. Moreover, myoblasts expressing constitu-
tive activated Notch1 (Myf5Cre:R26stop-NICD), survive
throughout development in the absence of myofibres,
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foetal stages and are surrounded by laminin, possibly
mimicking the niche [35].
Review and conclusion
As often reported in the past, the outcome of Notch signals
is profoundly dependent on the cellular context [68,69].
Muscle stem cells are no exception; pathway activity is
critical for maintaining proliferating stem cells during
growth, but also adult satellite cells, which are G0-arrested.
Generally, Notch action is pro-myogenic when it is linked
to inhibition of differentiation, but it can also suppress
growth in tissues where its physiological role is to induce
cell differentiation, for example in the skin [70,71]. The
quiescent state, however, constitutes an alternative, more
complex paradigm, where block of differentiation and re-
versible cell cycle arrest simultaneously co-exist. Once
again, distinct extrinsic and intrinsic factors seem to deter-
mine the phenotypic consequences of loss of Rbpj function
in satellite and adult neural stem cells, where the former
differentiate without entering S-phase during homeostasis
[13] and the latter collectively enter the cell cycle and
undergo transit amplification [14,15]. A major challenge in
the future is to identify the partners and the tissue specific
downstream targets of Notch signalling that influence the
developmental outcome of this fundamental signalling
pathway, and to elucidate the unique and common out-
comes of signalling through distinct Notch receptors in the
context of Rbpj function.
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